LOAME
CRL icon

Lombard Odier Asset Management (Europe)’s Charles River Laboratories CRL Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,800
Closed -$767K – 250
2023
Q1 		$767K Hold
3,800
– – 0.04% 238
2022
Q4 		$828K Sell
3,800
-100
-3% -$21.8K 0.03% 246
2022
Q3 		$768K Hold
3,900
– – 0.04% 233
2022
Q2 		$834K Buy
+3,900
New +$953K 0.04% 220

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s CRL Position: Q2 2023 in Review

Lombard Odier Asset Management (Europe) sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 3,800 shares — an estimated $767K sold.

Lombard Odier Asset Management (Europe) first reported a position in CRL in Q2 2022 and held it in 4 quarters. The position peaked at $834K in Q2 2022. 613 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

  • Lombard Odier Asset Management (Europe) reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 3,800 Charles River Laboratories shares in Q2 2023, an estimated $767K.
  • Lombard Odier Asset Management (Europe) first reported a position in Charles River Laboratories in Q2 2022 and held it in 4 quarters.
  • Lombard Odier Asset Management (Europe)'s Charles River Laboratories position peaked at $834K in Q2 2022.
  • 613 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q2 2023, filed 14 Aug 2023.